Frengki, Deddi P. Putra, Fatma Sri Wahyuni, Daan Khambri, Vivi Sofia
Frengki1,3*, Deddi P. Putra2, Fatma Sri Wahyuni2, Daan Khambri1 and Vivi Sofia4
1Department of Biomedicine, Faculty of Medicine, Andalas University, Padang, West Sumatera.
2Faculty of Pharmacy, Andalas University, Padang, West Sumatera.
3Faculty of Veterinary Medicine, Syiah Kuala University, Banda Aceh, Aceh.
4Department of Pharmacology and Clinical Pharmacy, Ahmad Dahlan University, Jogjakarta.
Volume - 14,
Issue - 5,
Year - 2021
Deoxyelephantopin is a lactone sesquiterpene compound that shows toxic effects on some cancer cells, otherwise, it is safe on normal cells. The combination of chemotherapy with this compound is intended to determine its effect in increasing the sensitivity of chemotherapy to MCF-7 cancer cells. Cell viability was determined through the MTT method (3-(4,5-dimethyl thiazol-2-il) -2,5-diphenyltetrazolium bromide) to determine the combined effect, while the number of cell deaths was determined through trypan blue staining. Giving deoxyelephantopin-doxorubicin combination to MCF-7 cells showed a synergistic effect with a CI < 0.7. The number of cells that died in the 1.52x and 2.12x combination treatments was higher than the single doxorubicin treatment each at IC50 and ½ IC50 concentrations, this confirms the synergistic effect of the combination. This research proves that deoxyelephantopin can increase the sensitivity and effectiveness of doxorubicin chemotherapy against MCF-7 breast cancer cells.
Cite this article:
Frengki, Deddi P. Putra, Fatma Sri Wahyuni, Daan Khambri, Vivi Sofia. The effect of Deoxyelephantopin enhances Doxorubicin Sensitivity to MCF-7 Cancer Cells. Research Journal of Pharmacy and Technology. 2021; 14(5):27915. doi: 10.52711/0974-360X.2021.00492
Frengki, Deddi P. Putra, Fatma Sri Wahyuni, Daan Khambri, Vivi Sofia. The effect of Deoxyelephantopin enhances Doxorubicin Sensitivity to MCF-7 Cancer Cells. Research Journal of Pharmacy and Technology. 2021; 14(5):27915. doi: 10.52711/0974-360X.2021.00492 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-5-76
1. Lacey, J. V., Devesa, S. S. and Brinton, L. A. Recent trends in breast cancer incidence and mortality. Environmental and Molecular Mutagenesis. 2002;39: 82-88
2. RI Ministry of Health. Datin Info "Data and Information Center of the Ministry of Health of the Republic of Indonesia". Jakarta. 2015
3. Childs A.C., Phaneuf S.L., Dirks A.J., Phillips, T. and Leeuwenburgh, Doxorubicin Treatment in Vivo Causes Cytochrome c Release and Cardiomyocyte Apoptosis, as Well as Increased Mitochondrial Efficiency, Superoxide Dismutase Activity, and Bcl-2: Bax ratio, Cancer Research. 2002; 62: 4592-4598
4. Bapsy P.P. and Sahoo T.P., Recent Advances in the Management of Metastatic Breast Cancer, Indian Journal Of Medical and Paediatric Oncology. 2004; 25(2): 19-27
5. Singal P.K., Iliskovic N., Li, T. and Kaur K. Heart Failure Due to Doxorubicin, Kuwait Medical Journal, 2001; 33(2): 111-115
6. Schlattner M.T., Zaugg M., Zuppinger C., Wallimann T., and Schlattner U. New Insights into Doxorubicin-induced Cardiotoxicity, The Critical Role of Cellular Energetics, Journal of Molecular and Cellular Cardiology. 2006; 41: 389-405
7. Press, M. F., Sauter, G., Buyse, M., Bernstein, L., Guzman, R., Santiago, A., Villalobos, I. E., Eiermann, W., Pienkowski, T. and Martin, M. Alteration of topoisomerase II–alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy. Journal of Clinical Oncolog., 2011; 29: 859-867.
8. Liu, Y., Du, F., Chen, W., Yao, M., Lv, K. and Fu, P. Knockdown of dual-specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF- 7/ADR breast cancer cells to doxorubicin. Experimental cell research. 2013; 319: 3140-3149.
9. Li, X., Lu, Y., Liang, K., Liu, B. and Fan, Z. Differential Responses to Doxorubicin-Induced Phosphorylation and Activation of Akt in Human Breast Cancer Cells. Breast Cancer Research. 2005; 7: 589-597.
10. Sui H, Fan Z-Z, Li Q. Signal Transduction Pathway and Transcriptional Mechanism of ABCB1/Pgp-Mediated Multiple Drug Resistance in Human Cancer Cells. The Medical Journal of International Research. 2012; 40: 426-235
11. Tyagi, A.K., Agarwal, C., Chan, D.C.F., dan Agarwal, R. Synergistic Anti-Cancer Effects of Silibinin with Conventional Cytotoxic Agents Doxorubicin, Cisplatin and Carboplatin Against Human Breast Carcinoma MCF-7 and MDA-MB468 Cells. Oncology Reports. 2004; 11: 493-499
12. Huang CC, Lo CP, Chiu CY, Shyur LF. Deoxyelephantopin a novel multifunctional agent, suppresses mammary tumor growth and lung metastasis and double survival time in mice. British Journal of Pharmacology. 2011;159(19): 856-871
13. Kabeer FA, Rajalakshmi DS, Nair MS, Prathapan R. Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells. Integr Med Res. 2017; 6: 190-206
14. Liang QL, Min ZD, Tang YP. A new elemanolide sesquiterpene lactone from Elephantopus scaber. Journal of Asian Natural Products Research. 2008; 10: 403-407
15. Su M, Chung HY, Li Y. Deoxyelephantopus sacaber L. induces cell cycle arrest and apoptosis in the human nasopharyngeal cancer CNE cells. Biochemical and Biophysical Research Communications. 2011; 411: 342-347
16. Su M, Wu X, Chung HY, Li Y, Ye W. Antiproliferative activities of five Chinese medicinal herbs and active compounds in Elephantophus scaber. Natural Product Communication. 2009; 4(8): 1025-1030
17. Xu G, Liang Q, Gong Z, Yu W, He S, Xi L. 2006. Antitumor activities of the four sesquiterpene lactone from E.Scaber L. Exp Oncol. 2006; 28(2): 106-109
18. Ichikawa H, Nasir MS, Takada Y, Alan Sheeja DB, Kumar s, Oommen OV, Aggarwal BB. Isodeoxyelephantophin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, abolishes osteoclastogenesis through suppression of NFkB activation and NFkB regulated gene expression. Clin Cancer Res. 2006; 12(19): 5910-5918
19. Geetha BS, Mangalam SN, Latha PG, Remani P. Sesquiterpene lactone isolated from E. Scaber L, inhibits human lymphocyte proliferation and the growth of tumor cell lines and induces apoptosis in vitro. J Biomed Biotechnol. 2012
20. Reynolds, C.P., dan Maurer, B.J. Evaluating Response to Antineoplastic Drug Combinations in Tissue Culture Models. Methods Mol. Med. 2005; 110: 173-183.
21. Shiddiqa A, M Long L, Li L, et al. Expression of HER-2 in MCF-7 Breast Cancer Cells Modulates anti-Apoptotic Protein Survivin and BcL-2 via The Extracellular Signal-Related Kinase (ERK) and Phosphoinositide-3 Kinase (PI3K) Signaling Pathway. BMC Cancer. 2008; 8: 129. doi:1186/1471-2407-8-129
22. Marklein d, Graab U, Naumann I, Yan T, et al. PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma Cells. 2012 PloS ONE 7(12). doi:10.1371/jounal.pone.0052898